Yousif Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.16M Sell
55,287
-3,172
-5% -$174K 0.04% 471
2026
Q1
$3.3M Sell
58,459
-3,025
-5% -$176K 0.04% 436
2025
Q4
$3.46M Sell
61,484
-1,398
-2% -$76.1K 0.04% 445
2025
Q3
$3.41M Sell
62,882
-4,158
-6% -$238K 0.04% 463
2025
Q2
$3.69M Sell
67,040
-1,021
-2% -$60.1K 0.04% 430
2025
Q1
$4.81M Sell
68,061
-1,708
-2% -$115K 0.06% 325
2024
Q4
$4.59M Sell
69,769
-3,068
-4% -$206K 0.05% 346
2024
Q3
$5.12M Sell
72,837
-9,308
-11% -$778K 0.06% 327
2024
Q2
$6.76M Buy
82,145
+79,731
+3,303% +$6.64M 0.08% 235
2024
Q1
$211K Buy
2,414
+198
+9% +$17.7K ﹤0.01% 1854
2023
Q4
$214K Buy
+2,216
New +$196K ﹤0.01% 1864
2023
Q2
Sell
-2,163
Closed -$210K 1969
2023
Q1
$210K Buy
2,163
+85
+4% +$8.81K ﹤0.01% 1825
2022
Q4
$215K Buy
+2,078
New +$195K ﹤0.01% 1811
2022
Q2
Sell
-2,641
Closed -$204K 1981
2022
Q1
$204K Buy
2,641
+55
+2% +$4.6K ﹤0.01% 1912
2021
Q4
$228K Buy
+2,586
New +$213K ﹤0.01% 1893

Other funds holding BMRN

Yousif Capital Management's BMRN Position: Q2 2026 in Review

Yousif Capital Management reduced its BioMarin Pharmaceuticals (BMRN) stake by 5.4% in Q2 2026, selling an estimated $174K and leaving 55,287 shares worth $3.16M. The position accounts for 0.04% of the portfolio, ranked #471.

Yousif Capital Management first reported a position in BMRN in Q4 2021 and has held it in 15 quarters since. The position peaked at $6.76M in Q2 2024. 88 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Yousif Capital Management held 55,287 shares of BioMarin Pharmaceuticals worth $3.16M as of Q2 2026.
  • Yousif Capital Management sold 3,172 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $174K.
  • BioMarin Pharmaceuticals made up 0.04% of Yousif Capital Management's portfolio in Q2 2026, its #471 holding.
  • Yousif Capital Management first reported a position in BioMarin Pharmaceuticals in Q4 2021 and has held it in 15 quarters since.
  • Yousif Capital Management's BioMarin Pharmaceuticals position peaked at $6.76M in Q2 2024.
  • 88 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.